Biodesix, Inc. (BDSX) Reports Q4 Loss, Beats Revenue Estimates

Biodesix, Inc. (BDSX) came out with a quarterly loss of $0.49 per share versus the Zacks Consensus Estimate of a loss of $1.05. This compares to a loss of $1.2 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +53.33%. A quarter ago, it was expected that this company would post a loss of $1.6 per share when it actually produced a loss of $1.16, delivering a surprise of +27.5%.Over the last four quarters, the company has surpasse ...